Baptista-Honet al. described a decrease in metastatic potential of colon cancer cells (SW620 cells) by ropivacaine and decrease of Nav1.5 function (adult and neonatal isoforms)122. This evidence concerns the gene SCN5A and malignant colon neoplasm.